| 4850 |
Centers for Disease Control and Prevention |
Html |
en |
Conjunctivitis: Prevention |
Prevent or reduce the risk of spreading or getting conjunctivitis by following some simple good hygiene steps. |
| Haemophilus influenzae type | 0.489173 |
| hand towels | 0.401294 |
| alcohol-based hand sanitizer | 0.693485 |
| warm water | 0.700892 |
| person’s eye | 0.412941 |
| tips | 0.364163 |
| detergent | 0.34545 |
| non-infected eyes | 0.419762 |
| bed linens | 0.400672 |
| hot water | 0.478286 |
| pink eye | 0.431867 |
| contact lenses | 0.917064 |
| Clean extended wear | 0.506209 |
| eye drops | 0.673085 |
| unwashed hands | 0.467954 |
| ointment | 0.356145 |
| proper handwashing | 0.510314 |
| washcloths | 0.385441 |
| eye | 0.693362 |
| bacterial diseases | 0.396838 |
| eye doctor | 0.495969 |
| contact lens storage | 0.647505 |
| pillows | 0.339036 |
| face makeup | 0.49399 |
| items | 0.40365 |
|
| personal items | 0.401624 |
| soap | 0.421201 |
| washing machine | 0.399103 |
| Clean eyeglasses | 0.53699 |
| CDC’s Clean | 0.532958 |
| eyes | 0.463917 |
| fresh cotton ball | 0.490253 |
| makeup brushes | 0.502727 |
| wet washcloth | 0.41259 |
| cotton balls | 0.402239 |
| good hygiene | 0.416778 |
| website | 0.341464 |
| disposable contact lenses | 0.502103 |
| lens storage cases | 0.652333 |
| conjunctivitis | 0.608772 |
| bacterial infection | 0.397122 |
| Clean Hands Save | 0.742529 |
| people | 0.344104 |
| infected person | 0.565358 |
| eye drop dispenser/bottle | 0.504499 |
| simple steps | 0.420014 |
| Wash pillowcases | 0.469356 |
| bacterial conjunctivitis | 0.496652 |
| risk | 0.343799 |
|
CLICK HERE |
| 4878 |
Centers for Disease Control and Prevention |
Html |
en |
Laboratory Detection of VISA/VRSA - HAI |
null |
| Clinical Microbiology | 0.428018 |
| glycopeptides | 0.43185 |
| oxacillin-resistant isolates | 0.670535 |
| important agent | 0.425033 |
| Slower growing cells | 0.525117 |
| antimicrobial agents | 0.646984 |
| Clinical Laboratory Standards. | 0.531973 |
| Vitek software | 0.426862 |
| S. epidermidis | 0.45952 |
| oxacillin-resistant CoNS | 0.524664 |
| single group | 0.438442 |
| term glycopeptide | 0.55447 |
| limits therapeutic options | 0.52436 |
| vancomycin MICs | 0.941659 |
| minimum inhibitory concentration | 0.537754 |
| S. McAllister | 0.429983 |
| Staphylococcus epidermidis | 0.440171 |
| S. haemolyticus | 0.533015 |
| Limited treatment options | 0.535066 |
| S. clinical trials | 0.568519 |
| decreased susceptibility | 0.784979 |
| Clinical Laboratory Standards | 0.727723 |
| hospital-acquired infections | 0.450867 |
| susceptibility test methods | 0.976905 |
| Reduced Susceptibility | 0.650154 |
|
| MicroScan rapid panels | 0.529938 |
| CoNS species | 0.559488 |
| therapeutic agents | 0.428191 |
| coagulase-negative staphylococci | 0.504446 |
| impaired host defenses | 0.556258 |
| infection control precautions | 0.533116 |
| commonly used susceptibility | 0.779578 |
| Yes. Staphylococci | 0.517635 |
| broader scope | 0.424819 |
| invasive devices | 0.435371 |
| antimicrobial susceptibility testing | 0.774268 |
| CoNS infection rate | 0.682577 |
| MicroScan conventional panels | 0.528428 |
| National Committee | 0.656785 |
| species level | 0.437345 |
| reduced susceptibilities | 0.425042 |
| clinical isolates | 0.693237 |
| clinical significance | 0.45635 |
| resistance trends | 0.429794 |
| routine susceptibility test | 0.759481 |
| treatment options | 0.536314 |
| New England Journal | 0.512618 |
| R.V. Spera | 0.422682 |
| vancomycin resistance | 0.760317 |
|
CLICK HERE |
| 8018 |
Centers for Disease Control and Prevention |
Html |
en |
South Africa - GeneXpert's Speedy Diagnosis gets Patients onto TB Treatment Quicker |
CDC partners in South Africa with government and parastatal agencies, private institutions, universities and non-governmental organizations to improve the country’s public health foundation, to prevent transmission of HIV, to provide care and treatment for those who are already infected with HIV, and to strengthen laboratory capacity.
|
| first-line drugs | 0.403138 |
| community health Center | 0.486644 |
| screen people | 0.390668 |
| two-hour drive | 0.404705 |
| Care Association project | 0.465359 |
| huge human investment | 0.463626 |
| effective treatment | 0.403049 |
| extreme weather | 0.405774 |
| nearest laboratory | 0.40101 |
| Disease Control | 0.408031 |
| huge success | 0.388863 |
| GeneXpert machine | 0.390664 |
| community care worker | 0.477524 |
| TB test | 0.682517 |
| CDC TB/HIV Care | 0.532901 |
| test results | 0.386129 |
| South African province | 0.496181 |
| Community Health Centre | 0.501381 |
| cutting-edge diagnostic machine | 0.496769 |
| TB patients | 0.709565 |
| rural setting | 0.407257 |
| community health workers | 0.677183 |
| drug-resistant TB | 0.780867 |
| drug resistance | 0.391569 |
| TB symptoms | 0.644927 |
|
| KZN | 0.360064 |
| entire community | 0.401112 |
| HIV epidemic | 0.397566 |
| TB culture | 0.674321 |
| high levels | 0.486123 |
| opportunistic infections | 0.39891 |
| speedy delivery | 0.390694 |
| rural clinic | 0.409694 |
| pholela community health | 0.626158 |
| long time | 0.396182 |
| TB infection | 0.668857 |
| mountainous terrain | 0.410559 |
| fewer people | 0.38994 |
| sputum sample | 0.487839 |
| TB treatment | 0.643974 |
| Pholela CHC | 0.392646 |
| TB/HIV Care Association | 0.81739 |
| TB cases | 0.66736 |
| PEPFAR | 0.335667 |
| susceptibility results | 0.400463 |
| drug resistant TB | 0.746011 |
| TB | 0.942606 |
| innovative diagnostics | 0.388398 |
| Rapid diagnosis | 0.392144 |
|
CLICK HERE |
| 8713 |
Centers for Disease Control and Prevention |
Html |
en |
Communication with Older Adults - Emergency Preparedness for Older Adults |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 9568 |
Centers for Disease Control and Prevention |
Html |
en |
Assessing the Risks for Poliovirus Outbreaks in Polio-FreeCountries - Africa, 2012-2013 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| risk assessments | 0.40896 |
| population immunity risk | 0.255111 |
| GPEI partners | 0.403444 |
| high-risk countries | 0.33964 |
| risk mitigation activities | 0.323637 |
| poliovirus transmission | 0.218242 |
| high-risk polio-free countries | 0.234078 |
| annual nonpolio AFP | 0.225654 |
| risk mitigation measures | 0.217939 |
| subnational areas | 0.216422 |
| high-risk subpopulations | 0.213879 |
| risk mitigation | 0.39645 |
| moderate-risk countries | 0.386857 |
| AFP cases | 0.229408 |
| AFP surveillance reviews | 0.265976 |
| population immunity indicator | 0.207993 |
| population immunity | 0.853829 |
| polio-free countries | 0.548499 |
|
| preventive SIAs | 0.388477 |
| AFP surveillance performance | 0.244144 |
| previously polio-free countries | 0.2286 |
| WPV importation belt | 0.781808 |
| active WPV transmission | 0.208327 |
| World Health Organization | 0.288954 |
| national AFP surveillance | 0.340556 |
| periodic preventive SIAs | 0.259677 |
| targeted subnational SIAs | 0.248431 |
| risk mitigation efforts | 0.217394 |
| WPV importation | 0.903406 |
| countries | 0.629189 |
| augment AFP surveillance | 0.242536 |
| West African WPV | 0.217546 |
| regional office | 0.231256 |
| WPV outbreaks | 0.334084 |
| limited AFP surveillance | 0.250744 |
| risk | 0.441567 |
|
CLICK HERE |
| 11190 |
Centers for Disease Control and Prevention |
Html |
en |
Ebola Radio Health Messages in Local Languages |
null |
| family members | 0.207668 |
| Transcript | 0.246035 |
| health care worker | 0.215138 |
| Outbreak Update | 0.22099 |
| sudden fever | 0.236014 |
| Page | 0.224357 |
| wild animals | 0.221573 |
|
| right information | 0.549541 |
| people | 0.2007 |
| Ebola virus | 0.601785 |
| remember | 0.234222 |
| health center | 0.207844 |
| health care workers | 0.891685 |
| Ebola patients | 0.3107 |
|
CLICK HERE |
| 11663 |
Centers for Disease Control and Prevention |
Html |
en |
Enterovirus D68 for Health Care Professionals |
Enterovirus D68 for Health Care Professionals. |
| Enterovirus D68 | 0.776694 |
| treatment | 0.333736 |
| general information | 0.505125 |
| EV-D68 testing | 0.499038 |
| overall effectiveness | 0.454478 |
| Asthma Care Quick | 0.667395 |
| Reinforce | 0.339232 |
| environmental disinfection specific | 0.609897 |
| alcohol-based hand rub | 0.609312 |
| enveloped viruses | 0.486345 |
| non-enveloped viruses | 0.468767 |
| EV-D68 infection | 0.580235 |
| summer | 0.333478 |
| local health department | 0.918095 |
| additional guidance | 0.471015 |
| oropharyngeal swabs | 0.501866 |
| state health departments | 0.636671 |
| local health departments | 0.634071 |
| specimen submission form | 0.620703 |
| respiratory specimens | 0.777928 |
| acute respiratory illness | 0.681624 |
| patient summary form | 0.612798 |
| risk factors | 0.496724 |
| skin tolerance | 0.463059 |
|
| non-polio enteroviruses | 0.561522 |
| vegetative bacteria | 0.472076 |
| adherence | 0.338124 |
| molecular typing | 0.664304 |
| patients | 0.364221 |
| wide variety | 0.46245 |
| diagnosis | 0.333762 |
| Overview | 0.333709 |
| asthma action plan | 0.675297 |
| CDC health | 0.592206 |
| Healthcare Settings | 0.461546 |
| rhinovirus | 0.330959 |
| specimen submission | 0.643017 |
| upper respiratory specimens | 0.757629 |
| symptoms | 0.333824 |
| infection control measures | 0.688851 |
| long-term control medication | 0.632659 |
| sera | 0.33482 |
| Contact your state | 0.628326 |
| healthcare pathogens | 0.462477 |
| hand hygiene | 0.591417 |
| possible cause | 0.49467 |
| Droplet Precautions | 0.508757 |
|
CLICK HERE |
| 15580 |
Centers for Disease Control and Prevention |
Html |
en |
Legal Preemption and the Prevention of Chronic Conditions |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| public health issues | 0.592629 |
| Massachusetts state regulation | 0.582786 |
| public health reforms | 0.602993 |
| public health interventions | 0.639687 |
| state law | 0.620843 |
| state governments | 0.593839 |
| public health innovations | 0.585732 |
| legal preemption | 0.595859 |
| New York City | 0.641096 |
| preemption scrutiny | 0.59085 |
| nutritional information | 0.62441 |
| state | 0.801526 |
| preemption litigation | 0.592215 |
| local governments | 0.696398 |
| uniform state law | 0.602783 |
| local laws | 0.84509 |
| public health areas | 0.597901 |
| federal law | 0.65245 |
| public health leaders | 0.645332 |
| public health objectives | 0.589217 |
| state laws | 0.611955 |
| law strips state | 0.605605 |
| state legislation | 0.583284 |
| Preemption themes | 0.590941 |
| federal laws | 0.647579 |
|
| legal public health | 0.605501 |
| conflicting state | 0.589868 |
| local labeling laws | 0.601948 |
| public health objective | 0.582554 |
| public health outcomes | 0.591815 |
| public health exercises | 0.590947 |
| public health laws | 0.644109 |
| public health goals | 0.62194 |
| public health | 0.965648 |
| local public sector | 0.611763 |
| public health law | 0.706083 |
| preemption starts | 0.598699 |
| conflicting local laws | 0.650564 |
| state preemption | 0.635276 |
| preemption issues | 0.588211 |
| chronic conditions | 0.750808 |
| local public health | 0.648541 |
| local legal innovations | 0.662059 |
| public health improvements | 0.630214 |
| public health practices | 0.594516 |
| preemption challenge | 0.587396 |
| Arizona State University | 0.639888 |
| meaningful policy proposals | 0.60596 |
| voluntary nutritional claims | 0.622784 |
|
CLICK HERE |
| 15772 |
Centers for Disease Control and Prevention |
Video |
en |
Take Pride in Your Job: Fall Protection |
NIOSH Publication No. 2009--108d http://www.cdc.gov/niosh/
This video encourages oil and gas extraction workers to use fall protection and never be "un-clipped" and thus vulnerable when at height. The video features oil and gas extraction workers talking about their use of fall protection and sharing their personal stories about why fall protection should always be worn when working at height. The purpose of the video is to raise awareness of fall injuries in this industry and to provide information about the use, proper fit, and inspection of fall protection. This video is designed to be used in pre-shift or weekly safety meetings. |
|
|
CLICK HERE |
| 16000 |
Centers for Disease Control and Prevention |
Html |
en |
Diagnostic Tests for Zika Virus |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
| NAT | 0.443641 |
| symptomatic non-pregnant individuals | 0.382414 |
| Zika virus | 0.951841 |
| IgM testing | 0.230247 |
| similar clinical illness | 0.23969 |
| Zika virus infection | 0.596289 |
| Trioplex Real-Time RT-PCR | 0.242418 |
| IgM serology | 0.531317 |
| NAT testing | 0.289755 |
| recent possible exposure | 0.244082 |
| testing algorithm | 0.334798 |
| symptomatic patient | 0.26029 |
| non-negative serology results | 0.2547 |
| RNA NAT | 0.249129 |
| symptomatic pregnant women | 0.849866 |
| congenital Zika virus | 0.357475 |
|
| Zika virus exposure | 0.293079 |
| NAT negative samples | 0.277609 |
| ongoing possible exposure | 0.241374 |
| prenatal ultrasound findings | 0.336492 |
| Zika virus NAT | 0.332057 |
| negative NAT result | 0.290087 |
| symptomatic persons | 0.248191 |
| IgM levels | 0.226482 |
| possible exposure | 0.414613 |
| physician-patient decision-making model | 0.22675 |
| PRNT Reference Center | 0.213273 |
| Zika virus-specific IgM | 0.290089 |
| asymptomatic pregnant women | 0.522362 |
| nucleic acid testing | 0.233892 |
| public health laboratory | 0.213416 |
|
CLICK HERE |